Across TCGA pan-cancer cohorts, FGF12-AS3 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated FGF12-AS3 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher FGF12-AS3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FGF12-AS3 expression acts as an unfavorable survival marker, although some lineages such as LGG and KIRP show a favorable association.
UCEC, LGG, and KIRP are the cancer types where FGF12-AS3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.